Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001246277 | SCV001419620 | uncertain significance | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2022-02-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 970669). This variant is also known as c.2266G>A (p.Val756Ile). This variant has not been reported in the literature in individuals affected with RTEL1-related conditions. This variant is present in population databases (rs142039934, gnomAD 0.003%). This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 732 of the RTEL1 protein (p.Val732Ile). |
Natera, |
RCV001829983 | SCV002095451 | uncertain significance | Dyskeratosis congenita | 2020-04-30 | no assertion criteria provided | clinical testing |